MGLIX | MGLJX | MGLIX / MGLJX | |
Total Expense Ratio | 0.94 | 1.94 | 48% |
Annual Report Gross Expense Ratio | 0.95 | 1.95 | 49% |
Fund Existence | 16 years | 10 years | - |
Gain YTD | 2.494 | 2.074 | 120% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.29B | 2.29B | 100% |
Annual Yield % from dividends | 2.53 | 1.54 | 164% |
Returns for 1 year | 3.42 | 2.39 | 143% |
Returns for 3 years | -9.29 | -12.00 | 77% |
Returns for 5 years | 11.20 | 5.76 | 195% |
Returns for 10 years | 32.20 | 11.45 | 281% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MAGCX | 27.90 | N/A | N/A |
BlackRock Advantage Global Institutional | |||
JFNAX | 63.85 | N/A | N/A |
Janus Henderson Global Life Sciences A | |||
UIVAX | 18.90 | N/A | N/A |
Victory Value Institutional | |||
AMIDX | 13.31 | N/A | N/A |
Amana Developing World Institutional | |||
RYAZX | 183.24 | N/A | N/A |
Rydex S&P SmallCap 600 Pure Value H |